Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanismsEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72017-07-0132PREAI
Evidence for nevirapine bioactivation in man: Searching for the first step in the mechanism of nevirapine toxicityTOXICOLOGYIF4.62012-11-0147OAAI
N-terminal valine adduct from the anti-HIV drug abacavir in rat haemoglobin as evidence for abacavir metabolism to a reactive aldehyde in vivoBRITISH JOURNAL OF PHARMACOLOGYIF7.72012-10-1917OAAI
Long-term maraviroc use as salvage therapy in HIV-2 infectionJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62012-06-2212OA